Publications by authors named "Caitlin S Yee"

Background: Generalized anxiety disorder (GAD) is a debilitating mental health disorder with first-line treatments include cognitive behavioral therapy (CBT) and pharmacotherapy. CBT is costly, time-consuming, and inaccessible. Electronic delivery (e-CBT) is a promising solution to address these barriers.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the effectiveness of an electronically delivered cognitive behavioral therapy (e-CBT) compared to traditional in-person therapy for individuals with major depressive disorder (MDD) during the COVID-19 pandemic.
  • Both treatment methods resulted in significant improvements in depressive symptoms and quality of life, with e-CBT showing higher participant compliance rates.
  • The research suggests that e-CBT with therapist support is a viable alternative for treating MDD, warranting further investigation in future studies.
View Article and Find Full Text PDF

Background: Psychotic disorders produce important morbidity and disability in children and adolescents. There have been few relevant treatment trials, encouraging assessment of research aimed at testing efficacy and safety of antipsychotics for juveniles. We aimed to compare the short- and long-term efficacy and safety of antipsychotics to treat psychotic disorders among children and adolescents.

View Article and Find Full Text PDF
Article Synopsis
  • - Major depressive disorder (MDD) is a common and severe mental health issue, with cognitive behavioral therapy (CBT) being the preferred treatment; however, access to traditional in-person CBT can be limited due to various barriers like stigma, cost, and wait times.
  • - This study explores the effectiveness and practicality of an online version of CBT (e-CBT) compared to traditional in-person CBT, hypothesizing that e-CBT will produce similar improvements in depressive symptoms and quality of life.
  • - Participants, aged 18-65, will engage in 12 weeks of e-CBT via a secure digital platform, completing modules and receiving personalized feedback, while their progress will be measured through validated questionnaires and focus groups will assess broader
View Article and Find Full Text PDF

Background: Generalized anxiety disorder (GAD) is an extremely prevalent and debilitating mental health disorder. Currently, the gold standard treatment for GAD is cognitive behavioral therapy (CBT) and/or pharmacotherapy. The most common medications used to treat GAD are selective serotonin reuptake inhibitors and selective norepinephrine reuptake inhibitors.

View Article and Find Full Text PDF

Learning Objective: After participating in this activity, learners should be better able to:• Evaluate the evidence regarding the effectiveness of long-term treatment of bipolar disorder with valproate.

Background: Prophylactic treatment is critical for bipolar disorder (BD) patients. Valproate is commonly used for this purpose but lacks regulatory approval and carries appreciable risks.

View Article and Find Full Text PDF

Background: Guidelines for maintenance treatment of juvenile bipolar disorder rely heavily on evidence from adult studies and relatively brief trials in juveniles, leaving uncertainties about optimal long-term treatment. We aimed to systematically review long-term treatment trials for juvenile bipolar disorder.

Methods: We analyzed data recovered by a systematic literature search using the PRISMA guidelines statement, through 2018, for peer-reviewed reports on pharmacological treatments for juvenile bipolar disorder lasting ≥24 weeks.

View Article and Find Full Text PDF